Serological response to COVID-19 vaccination in patients with cancer older than 80 years

Central studies carried out on vaccines against the severe acute respiratory syndrome coronavirus 2 (SARS-COV2) excluded patients receiving immunosuppressive therapy and those diagnosed with an immunosuppressive condition. Moreover, there are no data on vaccine efficacy regarding older patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Iacono, Daniela, Cerbone, Linda, Palombi, Lucia, Cavalieri, Elena, Sperduti, Isabella, Cocchiara, Rosario Andrea, Mariani, Bruno, Parisi, Gabriella, Garufi, Carlo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8192957/
https://www.ncbi.nlm.nih.gov/pubmed/34175246
http://dx.doi.org/10.1016/j.jgo.2021.06.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8192957/
https://www.ncbi.nlm.nih.gov/pubmed/34175246
http://dx.doi.org/10.1016/j.jgo.2021.06.002

Ejemplares similares